wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34077853-190F2136-F841-4CE5-A71F-173FD3113359
Q34077853-190F2136-F841-4CE5-A71F-173FD3113359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34077853-190F2136-F841-4CE5-A71F-173FD3113359
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer.
P2860
Q34077853-190F2136-F841-4CE5-A71F-173FD3113359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34077853-190F2136-F841-4CE5-A71F-173FD3113359
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e40d7a06ce1f9c840ddd4be0863a0bae43e5cce
P2860
Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy